Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Florbetapir (18F) Interpretation Training for Japanese Physicians
NCT02029547Withdrawn
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Oct 2014
- Primary completion
- May 2015
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Avid Radiopharmaceuticals. Primary endpoints: Inter Rater Reliability and Percent Agreement with Expert Panel. Planned start Oct 2014; status: withdrawn.
Beyond the preview
Go deeper on NCT02029547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02029547.